Ibrance Drug Interactions: 381 Major, 746 Moderate
Ibrance (Palbociclib) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ibrance. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Abacavir is combined with Palbociclib.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Abiraterone is combined with Palbociclib.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Palbociclib.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Palbociclib.
Level 2 evidence
Acebutolol
The risk or severity of liver damage can be increased when Acebutolol is combined with Palbociclib.
Level 2 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Aceclofenac is combined with Palbociclib.
Level 2 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Palbociclib.
Level 1 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Acetohydroxamic acid is combined with Palbociclib.
Level 2 evidence
Acetylcholine
The risk or severity of adverse effects can be increased when Palbociclib is combined with Acetylcholine.
Level 2 evidence
Acetylsalicylic acid
The risk or severity of liver damage can be increased when Acetylsalicylic acid is combined with Palbociclib.
Level 2 evidence
Acitretin
The risk or severity of liver damage can be increased when Acitretin is combined with Palbociclib.
Level 2 evidence
Acyclovir
The risk or severity of adverse effects can be increased when Palbociclib is combined with Acyclovir.
Level 2 evidence
Enter your NPI to unlock 28 major interactions for Ibrance
Ibrance (Palbociclib) has 1196 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ibrance (Palbociclib) has 381 major, 746 moderate, and 69 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ibrance. Always confirm against the full prescribing information.